Cargando…

Validation of a Saliva-Based Test for the Molecular Diagnosis of SARS-CoV-2 Infection

BACKGROUND: Since the beginning of the pandemic, clinicians and researchers have been searching for alternative tests to improve the screening and diagnosis of the SARS-CoV-2 infection. Currently, the gold standard for virus identification is the nasopharyngeal (NP) swab. Saliva samples, however, of...

Descripción completa

Detalles Bibliográficos
Autores principales: Bulfoni, Michela, Sozio, Emanuela, Marcon, Barbara, De Martino, Maria, Cesselli, Daniela, De Carlo, Chiara, Martinella, Romina, Migotti, Angelica, Vania, Eleonora, Zanus-Fortes, Agnese, De Piero, Jessica, Nencioni, Emanuele, Tascini, Carlo, Isola, Miriam, Curcio, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759915/
https://www.ncbi.nlm.nih.gov/pubmed/35035611
http://dx.doi.org/10.1155/2022/6478434
_version_ 1784633208228282368
author Bulfoni, Michela
Sozio, Emanuela
Marcon, Barbara
De Martino, Maria
Cesselli, Daniela
De Carlo, Chiara
Martinella, Romina
Migotti, Angelica
Vania, Eleonora
Zanus-Fortes, Agnese
De Piero, Jessica
Nencioni, Emanuele
Tascini, Carlo
Isola, Miriam
Curcio, Francesco
author_facet Bulfoni, Michela
Sozio, Emanuela
Marcon, Barbara
De Martino, Maria
Cesselli, Daniela
De Carlo, Chiara
Martinella, Romina
Migotti, Angelica
Vania, Eleonora
Zanus-Fortes, Agnese
De Piero, Jessica
Nencioni, Emanuele
Tascini, Carlo
Isola, Miriam
Curcio, Francesco
author_sort Bulfoni, Michela
collection PubMed
description BACKGROUND: Since the beginning of the pandemic, clinicians and researchers have been searching for alternative tests to improve the screening and diagnosis of the SARS-CoV-2 infection. Currently, the gold standard for virus identification is the nasopharyngeal (NP) swab. Saliva samples, however, offer clear, practical, and logistical advantages but due to a lack of collection, transport, and storage solutions, high-throughput saliva-based laboratory tests are difficult to scale up as a screening or diagnostic tool. With this study, we aimed to validate an intralaboratory molecular detection method for SARS-CoV-2 on saliva samples collected in a new storage saline solution, comparing the results to NP swabs to determine the difference in sensitivity between the two tests. METHODS: In this study, 156 patients (cases) and 1005 asymptomatic subjects (controls) were enrolled and tested simultaneously for the detection of the SARS-CoV-2 viral genome by RT-PCR on both NP swab and saliva samples. Saliva samples were collected in a preservative and inhibiting saline solution (Biofarma Srl). Internal method validation was performed to standardize the entire workflow for saliva samples. RESULTS: The identification of SARS-CoV-2 conducted on saliva samples showed a clinical sensitivity of 95.1% and specificity of 97.8% compared to NP swabs. The positive predictive value (PPV) was 81% while the negative predictive value (NPV) was 99.5%. Test concordance was 97.6% (Cohen's Kappa = 0.86; 95% CI 0.81-0.91). The LoD of the test was 5 viral copies for both samples. CONCLUSIONS: RT-PCR assays conducted on a stored saliva sample achieved similar performance to those on NP swabs, and this may provide a very effective tool for population screening and diagnosis. Collection of saliva in a stabilizing solution makes the test more convenient and widely available; furthermore, the denaturing properties of the solution reduce the infective risks belonging to sample manipulation.
format Online
Article
Text
id pubmed-8759915
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-87599152022-01-15 Validation of a Saliva-Based Test for the Molecular Diagnosis of SARS-CoV-2 Infection Bulfoni, Michela Sozio, Emanuela Marcon, Barbara De Martino, Maria Cesselli, Daniela De Carlo, Chiara Martinella, Romina Migotti, Angelica Vania, Eleonora Zanus-Fortes, Agnese De Piero, Jessica Nencioni, Emanuele Tascini, Carlo Isola, Miriam Curcio, Francesco Dis Markers Research Article BACKGROUND: Since the beginning of the pandemic, clinicians and researchers have been searching for alternative tests to improve the screening and diagnosis of the SARS-CoV-2 infection. Currently, the gold standard for virus identification is the nasopharyngeal (NP) swab. Saliva samples, however, offer clear, practical, and logistical advantages but due to a lack of collection, transport, and storage solutions, high-throughput saliva-based laboratory tests are difficult to scale up as a screening or diagnostic tool. With this study, we aimed to validate an intralaboratory molecular detection method for SARS-CoV-2 on saliva samples collected in a new storage saline solution, comparing the results to NP swabs to determine the difference in sensitivity between the two tests. METHODS: In this study, 156 patients (cases) and 1005 asymptomatic subjects (controls) were enrolled and tested simultaneously for the detection of the SARS-CoV-2 viral genome by RT-PCR on both NP swab and saliva samples. Saliva samples were collected in a preservative and inhibiting saline solution (Biofarma Srl). Internal method validation was performed to standardize the entire workflow for saliva samples. RESULTS: The identification of SARS-CoV-2 conducted on saliva samples showed a clinical sensitivity of 95.1% and specificity of 97.8% compared to NP swabs. The positive predictive value (PPV) was 81% while the negative predictive value (NPV) was 99.5%. Test concordance was 97.6% (Cohen's Kappa = 0.86; 95% CI 0.81-0.91). The LoD of the test was 5 viral copies for both samples. CONCLUSIONS: RT-PCR assays conducted on a stored saliva sample achieved similar performance to those on NP swabs, and this may provide a very effective tool for population screening and diagnosis. Collection of saliva in a stabilizing solution makes the test more convenient and widely available; furthermore, the denaturing properties of the solution reduce the infective risks belonging to sample manipulation. Hindawi 2022-01-07 /pmc/articles/PMC8759915/ /pubmed/35035611 http://dx.doi.org/10.1155/2022/6478434 Text en Copyright © 2022 Michela Bulfoni et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Bulfoni, Michela
Sozio, Emanuela
Marcon, Barbara
De Martino, Maria
Cesselli, Daniela
De Carlo, Chiara
Martinella, Romina
Migotti, Angelica
Vania, Eleonora
Zanus-Fortes, Agnese
De Piero, Jessica
Nencioni, Emanuele
Tascini, Carlo
Isola, Miriam
Curcio, Francesco
Validation of a Saliva-Based Test for the Molecular Diagnosis of SARS-CoV-2 Infection
title Validation of a Saliva-Based Test for the Molecular Diagnosis of SARS-CoV-2 Infection
title_full Validation of a Saliva-Based Test for the Molecular Diagnosis of SARS-CoV-2 Infection
title_fullStr Validation of a Saliva-Based Test for the Molecular Diagnosis of SARS-CoV-2 Infection
title_full_unstemmed Validation of a Saliva-Based Test for the Molecular Diagnosis of SARS-CoV-2 Infection
title_short Validation of a Saliva-Based Test for the Molecular Diagnosis of SARS-CoV-2 Infection
title_sort validation of a saliva-based test for the molecular diagnosis of sars-cov-2 infection
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759915/
https://www.ncbi.nlm.nih.gov/pubmed/35035611
http://dx.doi.org/10.1155/2022/6478434
work_keys_str_mv AT bulfonimichela validationofasalivabasedtestforthemoleculardiagnosisofsarscov2infection
AT sozioemanuela validationofasalivabasedtestforthemoleculardiagnosisofsarscov2infection
AT marconbarbara validationofasalivabasedtestforthemoleculardiagnosisofsarscov2infection
AT demartinomaria validationofasalivabasedtestforthemoleculardiagnosisofsarscov2infection
AT cessellidaniela validationofasalivabasedtestforthemoleculardiagnosisofsarscov2infection
AT decarlochiara validationofasalivabasedtestforthemoleculardiagnosisofsarscov2infection
AT martinellaromina validationofasalivabasedtestforthemoleculardiagnosisofsarscov2infection
AT migottiangelica validationofasalivabasedtestforthemoleculardiagnosisofsarscov2infection
AT vaniaeleonora validationofasalivabasedtestforthemoleculardiagnosisofsarscov2infection
AT zanusfortesagnese validationofasalivabasedtestforthemoleculardiagnosisofsarscov2infection
AT depierojessica validationofasalivabasedtestforthemoleculardiagnosisofsarscov2infection
AT nencioniemanuele validationofasalivabasedtestforthemoleculardiagnosisofsarscov2infection
AT tascinicarlo validationofasalivabasedtestforthemoleculardiagnosisofsarscov2infection
AT isolamiriam validationofasalivabasedtestforthemoleculardiagnosisofsarscov2infection
AT curciofrancesco validationofasalivabasedtestforthemoleculardiagnosisofsarscov2infection